SARS CoV-2 Recombinant Antibodies

Exonbio has developed an extensive portfolio of antibodies against SARS-CoV-2 Spike and Nucleocapsid proteins. The virus attaches to the cell that through an interaction between the spike protein on the surface of the viral particle and a receptor protein, ACE2 on the surface of the cell. The antibodies bind to the spike protein and prevent it from interacting with ACE2 receptor on the host cell, neutralizing the virus making it unable to infect the cells. The nucleocapsid protein is highly immunogenic phosphoprotein. It is also involved in CoV replication cycle and the host cellular response to viral infection. 

Exonbio has developed hundreds of clones of rabbit monoclonal antibodies using proprietary SPIN® technology. SARS-CoV-2 Reagent Antigens

Catalog No Antigen Product Description Host Animal Clonality
RN150-P10 Nucleocapsid Anti-SARS CoV-2 Nucleocapsid Antibody, panel of 10 clones Rabbit Monoclonal
RN150-Clone# Nucleocapsid SARS-CoV-2 Nucleocapsid Antibody, individual clones Rabbit Monoclonal
RPN-211 Nucleocapsid Anti-SARS CoV-2 Nucleocapsid Antibody Rabbit Polyclonal
RS110-P10 Spike protein, S1 Subunit Anti-SARS CoV-2 Spike S1 Antibody,  panel of 10 clones Rabbit Monoclonal
RS110-Clone# Spike protein, S1 Subunit Anti-SARS CoV-2 Spike Antibody, individual clones Rabbit Monoclonal
RPS-205 Spike protein, S1 Subunit SARS-CoV-2 Spike S1 Antibody Rabbit Polyclonal
PACS1-14953 Spike Peptides SARS-CoV-2 Spike Antibody Rabbit Polyclonal
exo-CR3002 Spike RBD Human anti-COVID19 IgG Positive control Human Monoclonal
exo-CR4002 Spike RBD Human anti-COVID19 IgM Positive Control  Human  Monoclonal